Cargando…
Hemodialysis (HD) dose and ultrafiltration rate are associated with survival in pediatric and adolescent patients on chronic HD—a large observational study with follow-up to young adult age
BACKGROUND: Hemodialysis (HD) dose targets and ultrafiltration rate (UFR) limits for pediatric patients on chronic HD are not known and are derived from adults (spKt/V>1.4 and <13 ml/kg/h). We aimed to characterize how delivered HD dose and UFR are associated with survival in a large cohort of...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260402/ https://www.ncbi.nlm.nih.gov/pubmed/33651178 http://dx.doi.org/10.1007/s00467-021-04972-6 |
_version_ | 1783718805865758720 |
---|---|
author | Gotta, Verena Marsenic, Olivera Atkinson, Andrew Pfister, Marc |
author_facet | Gotta, Verena Marsenic, Olivera Atkinson, Andrew Pfister, Marc |
author_sort | Gotta, Verena |
collection | PubMed |
description | BACKGROUND: Hemodialysis (HD) dose targets and ultrafiltration rate (UFR) limits for pediatric patients on chronic HD are not known and are derived from adults (spKt/V>1.4 and <13 ml/kg/h). We aimed to characterize how delivered HD dose and UFR are associated with survival in a large cohort of patients who started HD in childhood. METHODS: Retrospective analysis on a cohort of patients <30 years, on chronic HD since childhood (<19 years), having received thrice-weekly HD 2004–2016 in outpatient DaVita centers. Outcome: Survival while remaining on HD. Predictors: (I) primary analysis: mean delivered dialysis dose stratified as spKt/V ≤1.4/1.4–1.6/>1.6 (Kaplan–Meier analysis), (II) secondary analyses: UFR and alternative dialysis adequacy measures [eKt/V, body-surface normalized Kt/BSA] on continuous scale (Weibull regression model). RESULTS: A total of 1780 patients were included (age at the start of HD: 0–12y: n=321, >12–18y: n=1459; median spKt/V=1.55, eKt/V=1.31, Kt/BSA=31.2 L/m(2), UFR=10.6 mL/kg/h). (I) spKt/V<1.4 was associated with lower survival compared to spKt/V>1.4–1.6 (P<0.001, log-rank test), and spKt/V>1.6 (P<0.001), with 10-year survival of 69.3% (59.4–80.9%) versus 83.0% (76.8–89.8%) and 84.0% (79.6–88.5%), respectively. (II) Kt/BSA was a better predictor of survival than spKt/V or eKt/V. UFR was additionally associated with survival (P<0.001), with increased mortality <10/>18 mL/kg/h. Associations did not alter significantly following adjustment for demographic characteristics (age, etiology of kidney disease, and ethnicity). CONCLUSIONS: Our results suggest usefulness of targeting Kt/BSA>30 L/m(2) for best long-term outcomes, corresponding to spKt/V>1.4 (>12 years) and >1.6 (<12 years). In contrast to adults, higher UFR of 10–18 ml/kg/h was not associated with greater mortality in this population. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00467-021-04972-6. |
format | Online Article Text |
id | pubmed-8260402 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-82604022021-07-20 Hemodialysis (HD) dose and ultrafiltration rate are associated with survival in pediatric and adolescent patients on chronic HD—a large observational study with follow-up to young adult age Gotta, Verena Marsenic, Olivera Atkinson, Andrew Pfister, Marc Pediatr Nephrol Original Article BACKGROUND: Hemodialysis (HD) dose targets and ultrafiltration rate (UFR) limits for pediatric patients on chronic HD are not known and are derived from adults (spKt/V>1.4 and <13 ml/kg/h). We aimed to characterize how delivered HD dose and UFR are associated with survival in a large cohort of patients who started HD in childhood. METHODS: Retrospective analysis on a cohort of patients <30 years, on chronic HD since childhood (<19 years), having received thrice-weekly HD 2004–2016 in outpatient DaVita centers. Outcome: Survival while remaining on HD. Predictors: (I) primary analysis: mean delivered dialysis dose stratified as spKt/V ≤1.4/1.4–1.6/>1.6 (Kaplan–Meier analysis), (II) secondary analyses: UFR and alternative dialysis adequacy measures [eKt/V, body-surface normalized Kt/BSA] on continuous scale (Weibull regression model). RESULTS: A total of 1780 patients were included (age at the start of HD: 0–12y: n=321, >12–18y: n=1459; median spKt/V=1.55, eKt/V=1.31, Kt/BSA=31.2 L/m(2), UFR=10.6 mL/kg/h). (I) spKt/V<1.4 was associated with lower survival compared to spKt/V>1.4–1.6 (P<0.001, log-rank test), and spKt/V>1.6 (P<0.001), with 10-year survival of 69.3% (59.4–80.9%) versus 83.0% (76.8–89.8%) and 84.0% (79.6–88.5%), respectively. (II) Kt/BSA was a better predictor of survival than spKt/V or eKt/V. UFR was additionally associated with survival (P<0.001), with increased mortality <10/>18 mL/kg/h. Associations did not alter significantly following adjustment for demographic characteristics (age, etiology of kidney disease, and ethnicity). CONCLUSIONS: Our results suggest usefulness of targeting Kt/BSA>30 L/m(2) for best long-term outcomes, corresponding to spKt/V>1.4 (>12 years) and >1.6 (<12 years). In contrast to adults, higher UFR of 10–18 ml/kg/h was not associated with greater mortality in this population. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00467-021-04972-6. Springer Berlin Heidelberg 2021-03-02 2021 /pmc/articles/PMC8260402/ /pubmed/33651178 http://dx.doi.org/10.1007/s00467-021-04972-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Gotta, Verena Marsenic, Olivera Atkinson, Andrew Pfister, Marc Hemodialysis (HD) dose and ultrafiltration rate are associated with survival in pediatric and adolescent patients on chronic HD—a large observational study with follow-up to young adult age |
title | Hemodialysis (HD) dose and ultrafiltration rate are associated with survival in pediatric and adolescent patients on chronic HD—a large observational study with follow-up to young adult age |
title_full | Hemodialysis (HD) dose and ultrafiltration rate are associated with survival in pediatric and adolescent patients on chronic HD—a large observational study with follow-up to young adult age |
title_fullStr | Hemodialysis (HD) dose and ultrafiltration rate are associated with survival in pediatric and adolescent patients on chronic HD—a large observational study with follow-up to young adult age |
title_full_unstemmed | Hemodialysis (HD) dose and ultrafiltration rate are associated with survival in pediatric and adolescent patients on chronic HD—a large observational study with follow-up to young adult age |
title_short | Hemodialysis (HD) dose and ultrafiltration rate are associated with survival in pediatric and adolescent patients on chronic HD—a large observational study with follow-up to young adult age |
title_sort | hemodialysis (hd) dose and ultrafiltration rate are associated with survival in pediatric and adolescent patients on chronic hd—a large observational study with follow-up to young adult age |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260402/ https://www.ncbi.nlm.nih.gov/pubmed/33651178 http://dx.doi.org/10.1007/s00467-021-04972-6 |
work_keys_str_mv | AT gottaverena hemodialysishddoseandultrafiltrationrateareassociatedwithsurvivalinpediatricandadolescentpatientsonchronichdalargeobservationalstudywithfollowuptoyoungadultage AT marsenicolivera hemodialysishddoseandultrafiltrationrateareassociatedwithsurvivalinpediatricandadolescentpatientsonchronichdalargeobservationalstudywithfollowuptoyoungadultage AT atkinsonandrew hemodialysishddoseandultrafiltrationrateareassociatedwithsurvivalinpediatricandadolescentpatientsonchronichdalargeobservationalstudywithfollowuptoyoungadultage AT pfistermarc hemodialysishddoseandultrafiltrationrateareassociatedwithsurvivalinpediatricandadolescentpatientsonchronichdalargeobservationalstudywithfollowuptoyoungadultage |